Boehringer Ingelheim’s Apecotrep Delivers 40% Proteinuria Reduction in Phase II Primary FSGS Trial

Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive the...

January 29, 2026 | Thursday | News
Roche’s CT-388 Delivers 22.5% Placebo-Adjusted Weight Loss in Phase II Obesity Trial

A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% (p < 0.001) at 48 weeks at...

January 28, 2026 | Wednesday | News
Is AI Pharma’s ‘Fool’s Gold’? Why Evidence-Driven Metrics Will Define Real ROI

  AI's presence in pharma & animal health is rapidly expanding – the global AI pharmaceutical market is expected to grow to tens of billion...

January 26, 2026 | Monday | Opinion
Epcoritamab Demonstrates Statistically Significant PFS Improvement in Phase 3 DLBCL Study

Based on the topline results from the EPCORE® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss next steps Ge...

January 20, 2026 | Tuesday | News
Daiichi Sankyo and AstraZeneca Secure EMA Validation for ENHERTU Combination in First-Line HER2-Positive Metastatic Breast Cancer

Based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s ENHERTU in combination with pertuzumab significant...

January 20, 2026 | Tuesday | News
Johnson & Johnson: CAPLYTA® Nearly Doubles Remission Rates at Six Weeks as Adjunctive Therapy in Major Depressive Disorder

CAPLYTA® nearly doubled the likelihood of remission at six weeks compared to placebo as an adjunctive therapy to an antidepressant based on pooled da...

January 19, 2026 | Monday | News
Linus Health Accelerates AI-Driven Early Brain Health Detection as Dementia Burden Surges and Industry Momentum Builds

2026 is already shaping up to be a historic year for brain health as the healthcare industry confronts an urgent reality: cognitive impairment, Alzheimer...

January 19, 2026 | Monday | News
AbbVie and Genmab Report Positive PFS Results from Phase 3 EPCORE® DLBCL-1 Trial of Epcoritamab in Relapsed/Refractory DLBCL

Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss ...

January 19, 2026 | Monday | News
Tensive Reports Positive Pivotal Trial Results for REGENERA™ in Lumpectomy Patients

Clinical data from pivotal trial in patients undergoing lumpectomy confirm strong safety profile and growing performance benefits Primary safety endp...

January 09, 2026 | Friday | News
Zenas BioPharma Shares Slide On Phase 3 Data Focus

    Market participants appear to be adopting a wait and watch stance, with sentiment shaped less by near term fundamentals and more by expecta...

January 05, 2026 | Monday | News
Tiger BioSciences Strengthens Clinical Leadership With Expanded Evidence-Based Research in 2025

Tiger BioSciences highlights a series of major clinical and scientific achievements resulting from the company's expanded investment in evidence‑based ...

January 01, 2026 | Thursday | News
Mereo BioPharma’s Phase 3 Setrusumab Studies Miss Primary Fracture Endpoints in Osteogenesis Imperfecta

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates (COSMIC) Bo...

December 31, 2025 | Wednesday | News
Viva Biotech Showcases Integrated PK/PD Platform Across Small Molecules, Peptides, PROTACs, and Antibodies

Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and m...

December 30, 2025 | Tuesday | News
Biohaven Reports Phase 2 Results for BHV-7000 in Major Depressive Disorder

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization o...

December 26, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close